Advertisement

Table of Contents

November 01, 1984; Volume 26,Issue 3

You have access
Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
T Evans, M M Smith, L I Tanner and T K Harden

Molecular Pharmacology November 1984, 26 (3) 395-404;
You have access
The relationship between phosphatidylinositol metabolism and mobilization of intracellular calcium elicited by alpha1-adrenergic receptor stimulation in BC3H-1 muscle cells.
S K Ambler, R D Brown and P Taylor

Molecular Pharmacology November 1984, 26 (3) 405-413;
You have access
Purification and characterization of (-)[125I]hydroxyphenylisopropyladenosine, an adenosine R-site agonist radioligand and theoretical analysis of mixed stereoisomer radioligand binding.
J Linden

Molecular Pharmacology November 1984, 26 (3) 414-423;
You have access
Use of a density shift method to assess beta-adrenergic receptor synthesis during recovery from catecholamine-induced down-regulation in human astrocytoma cells.
G L Waldo, R C Doss, J P Perkins and T K Harden

Molecular Pharmacology November 1984, 26 (3) 424-429;
You have access
[3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
T Nakajima and K Iwata

Molecular Pharmacology November 1984, 26 (3) 430-438;
You have access
Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
A A Hancock and C L Marsh

Molecular Pharmacology November 1984, 26 (3) 439-451;
You have access
Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
M P Seiler and R Markstein

Molecular Pharmacology November 1984, 26 (3) 452-457;
You have access
Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors.
R R Trifiletti and S H Snyder

Molecular Pharmacology November 1984, 26 (3) 458-469;
You have access
Anxiolytic cyclopyrrolone drugs allosterically modulate the binding of [35S]t-butylbicyclophosphorothionate to the benzodiazepine/gamma-aminobutyric acid-A receptor/chloride anionophore complex.
R R Trifiletti, A M Snowman and S H Snyder

Molecular Pharmacology November 1984, 26 (3) 470-476;
You have access
Binding of [3H]naloxonazine to rat brain membranes.
N Johnson and G W Pasternak

Molecular Pharmacology November 1984, 26 (3) 477-483;
You have access
Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
K J Chang, S G Blanchard and P Cuatrecasas

Molecular Pharmacology November 1984, 26 (3) 484-488;
You have access
Opiate-receptor interactions on single locus coeruleus neurones.
J T Williams and R A North

Molecular Pharmacology November 1984, 26 (3) 489-497;
You have access
Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
A De Léan, H Ong, J Gutkowska, P W Schiller and N McNicoll

Molecular Pharmacology November 1984, 26 (3) 498-508;
You have access
Cellular pathways of galactose-terminal ligand movement in a cloned human hepatoma cell line.
C F Simmons and A L Schwartz

Molecular Pharmacology November 1984, 26 (3) 509-519;
You have access
Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
W L Duax, D C Swenson, P D Strong, K S Korach, J McLachlan and M Metzler

Molecular Pharmacology November 1984, 26 (3) 520-525;
You have access
Progesterone inhibition of Xenopus oocyte adenylate cyclase is not mediated via the Bordetella pertussis toxin substrate.
S E Sadler, J L Maller and D M Cooper

Molecular Pharmacology November 1984, 26 (3) 526-531;
You have access
Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.
A C Howlett and R M Fleming

Molecular Pharmacology November 1984, 26 (3) 532-538;
You have access
Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.
S Jaques, M C Tobes, J C Sisson, J A Baker and D M Wieland

Molecular Pharmacology November 1984, 26 (3) 539-546;
You have access
Genetic influences on the central nervous system depressant and membrane-disordering actions of ethanol and sodium valproate.
B J Perlman and D B Goldstein

Molecular Pharmacology November 1984, 26 (3) 547-552;
You have access
The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes.
J S Schanche, T Schanche, P M Ueland, A Holý and I Votruba

Molecular Pharmacology November 1984, 26 (3) 553-558;
You have access
Inhibition of erythrocyte sickling by thiol reagents.
M C Garel, C Domenget, F Galacteros, J Martin-Caburi and Y Beuzard

Molecular Pharmacology November 1984, 26 (3) 559-565;
You have access
Effect of cytosolic components on the metabolism of the hydrazide iproniazid.
M E Spearman, S J Moloney and R A Prough

Molecular Pharmacology November 1984, 26 (3) 566-573;
You have access
Reducing equivalents for mixed function oxidation in periportal and pericentral regions of the liver lobule in perfused livers from normal and phenobarbital-treated rats.
S A Belinsky, F C Kauffman and R G Thurman

Molecular Pharmacology November 1984, 26 (3) 574-581;
You have access
Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
P L Gutierrez, B M Fox, M M Mossoba and N R Bachur

Molecular Pharmacology November 1984, 26 (3) 582-586;
You have access
Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
T C Chou, C Lopez, J M Colacino, A Feinberg, K A Watanabe, J J Fox and F S Philips

Molecular Pharmacology November 1984, 26 (3) 587-593;
You have access
Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo.
L J Lu and K Randerath

Molecular Pharmacology November 1984, 26 (3) 594-603;